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DegradationSequence-non-speciﬁc effects of siRNAs that alter the expression of non-targeted genes have been reported,
including competition of siRNAs with endogenous RISC components. However, the detailed mechanisms and
subsequent effects of such competition are not well documented. Here we analyze the competition of miRNAs
in mammalian cells with low concentrations of siRNAs, and found that: 1) transfection of different siRNAs in
the low nanomolar range used to deplete target RNAs can reduce the levels of miRNAs in different cell types,
2) siRNA transfection results in rapid reduction of Ago2-associated miRNAs concurrent with accumulation of
Ago2-bound siRNAs and a signiﬁcant change in the expression levels of many miRNAs, 3) competition largely
depends on Ago2 and not Dicer, 4) microarray analysis showed that the majority of highly expressed miRNAs
are reduced, in a siRNA concentration dependent manner, and low abundant miRNAs may be unchanged or
repressed and a fewmiRNAs appear to have increased levels, and 5) consistent with previous studies, the expres-
sion levels of mRNAs that are targeted by highly repressed miRNAs are preferentially increased. As a consequence
of such competition, we observed that α-tubulin, a substrate of two up-regulated proteases, granzyme B and
granzyme M, was rapidly degraded at the protein level upon siRNA transfection. Our results support a model
in which transfection of siRNAs can change the levels of many miRNAs by competition for Ago2, leading to
altered expression of many miRNA target genes, which can in turn affect downstream gene expression even at
the protein level.
© 2013 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
RNA interference (RNAi) is a process by which dsRNA triggers
speciﬁc degradation of homologous mRNAs [1]. RNAi is mediated by
small interfering RNAs (siRNAs), 21–24 nts double stranded RNAs
(dsRNAs) that are either transfected as in vitro synthesized form, or
expressed in cells as long dsRNAs or small hairpin RNAs (shRNAs)
that are processed into siRNAs using endogenous proteins including
Dicer. The double stranded siRNAs are incorporated into the RNA
induced silencing complex (RISC) containing Ago2. The passenger
strand of the siRNA duplex is released from the complex, leaving only
the guide strand associated with Ago2. The guide strand siRNA directs
the RISC to substrate mRNA, which is cleaved by Ago2, resulting
in sequence-speciﬁc mRNA cleavage through perfect base-pairing of
siRNAs with target mRNAs (e.g., [2–4]).lex; MEF, mouse embryonic
e Research, ISIS Pharmaceuticals,
760 603 3816; fax: +1 760 603
Y-NC-ND license.Closely related to siRNAs are miRNAs, a group of endogenously
expressed small RNAs that mainly function in down-regulating gene
expression through imperfect base-pairing with target mRNAs, either
by inhibiting translation or by modulating mRNA stability [3,4].
In part because miRNA:mRNA base-pairing involves only a short
seed sequence, a single miRNA can target multiple mRNAs and a
single mRNA can be regulated by multiple miRNAs, creating a huge,
complex miRNA regulation network. Indeed, it was proposed that
more than half of the human protein coding genes can be targeted
by miRNAs [5].
siRNAs and miRNAs utilize overlapping cellular machinery for
biogenesis and function. For example, both siRNAs and miRNAs
associate with Ago2 in mammals, the core protein component of the
RISC complex. It has been demonstrated that siRNAs and miRNAs
can be functionally inter-changeable by altering the base-pairing pat-
terns with mRNA targets [6]. Thus, siRNA can lead to mis-regulation
of other non-target genes by functioning like miRNAs through
imperfect base-pairing, or by inducing non-speciﬁc mRNA cleavage
via near-perfect base-pairing, causing RISC dependent off-target
effects [7]. It has also been shown that expression of shRNAs
that are processed into siRNAs in cells can compete with Exportin 5,
a protein involved in export of miRNA/siRNA from the nucleus to
the cytoplasm, leading to reduction of miRNA levels [8,9]. However,
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for cytoplasmic localization reduces the level of miRNAs. Further,
conﬂicting observations of siRNA effects on miRNA expression levels
have been reported. For example, John et al. reported that administra-
tion of siRNAs in the mouse did not reduce levels of miRNAs [10],
whereas Khan et al. discovered the up-regulation of a large number
of mRNAs that are potentially targeted by miRNAs when cells are
transfected with siRNAs or miRNAs, based on bioinformatics analysis
of 151 experiments involving 29 different miRNAs and 42 different
siRNAs [11]. These reports and observations suggest that the transfec-
tion of RISC-associated small RNAs can disturb endogenous miRNA
function probably by saturating the RISC pathway. However, a detailed
mechanism has not been well demonstrated. For example, do siRNAs
competewith RISC components such as Dicer to impairmiRNA process-
ing or compete with Ago2 protein at mature miRNA level?
In this study, we further characterized the competition between
siRNAs and miRNAs and found that competition can occur rapidly
even at low siRNA concentrations, leading to altered levels of many
endogenous miRNAs. Further, we found that the most affected miRNAs
were the most highly expressed miRNAs. Consequently, transfection
of siRNAs leads to altered expression of many genes, in a siRNA
concentration dependent manner. Lastly we demonstrated that this
mis-regulation can cause changes at the protein level. We provide a
detailed dissection of this general mechanism using a speciﬁc case
where the transfection of different siRNAs can non-speciﬁcally trigger
rapid degradation of α-tubulin protein, in a dose-dependent manner.
2. Materials and methods
2.1. Materials
Antibodies, siRNAs, RNaseH-dependent oligonucleotides, qRT-PCR
primers and probes, and oligonucleotide probes for northern hybridiza-
tion are listed in Supplemental materials.
2.2. Cell culture and transfection
HeLa, HEK293, and mouse embryonic ﬁbroblast (MEF) cells were
cultured in DMEM supplemented with 10% FBS, 0.1 μg/ml streptomycin,
and 100 units/ml penicillin. Transfection of siRNAs was performed
in DMEM medium supplemented with 10% FBS, using 5 μg/ml
Lipofectamine RNAiMax, based on the manufacturer's procedure.
Starting cell conﬂuency was ~50%, otherwise as indicated in ﬁgure
legends.
2.3. Western analysis
Equal amounts of proteins (~8–25 μg, or as indicated in the ﬁgure
legends) were separated in 4–12% SDS PAGE and transferred to
membrane. Blocking anddetection of proteinswith ECLwere performed
as described in [12].
2.4. Northern hybridization and qRT-PCR
Northern hybridization and qRT-PCR using TaqMan primer probe
sets were performed as described in [12]. For miRNA detection, total
RNA was isolated from cells using miRNeasy kit (Qiagen), based
on the manufacturer's protocol, and miRNAs were detected either
by northern hybridization using 5′ end-labeled oligonucleotides, or
by qRT-PCR using TaqMan miRNA assay (Applied Biosystems), based
on the manufacturer's protocol. Brieﬂy, 5 μl total RNA (500 ng) or
Ago2 co-precipitated RNAs were reverse transcribed in a 20 μl reaction
containing 4 μl 5× RT buffer, 2 μl 10 mM dNTP, 1 μl RT primer speciﬁc
to miRNAs or siRNA (from Applied Systems), 1.5 μl 25 mM MgCl2,
1 μl reverse transcriptase (RMV), 0.5 μl RNase inhibitor (Promega),
and 5 μl DEPC water. The reaction was performed at 16 °C for 30 min,42 °C for 30 min, and stopped by heating at 85 °C for 5 min. The reaction
was 1:2 diluted with DDW, and 4 μl diluted cDNA was used in a 10 μl
qRT-PCR reaction containing 5 μl 2× master mix (Applied Biosystems)
and 1 μl primer probe mix (Applied Biosystems) speciﬁc to the miRNAs
or siRNAs. The qRT-PCR program was: 95 °C for 10 min, followed by
40 cycles of 95 °C for 15 s and 60 °C for 20 s. The levels of miRNAs
detected by qRT-PCR were normalized to U16 snoRNA level.
2.5. Microarray analyses
HeLa cells were treated for 24 h with 3 nM or 6 nM FEN1 siRNA,
or 6 nM RHA siRNA. RNA was prepared using miRNeasy mini kit
(Qiagen) and treated with DNase to remove DNA contamination.
Reduction of the targeted FEN1 and RHA mRNAs was conﬁrmed
using qRT-PCR. Microarray analyses for miRNAs (Human miRNA 2.1
Expression) and mRNAs (Onearray Hybridization) were performed
by Phalanx Biotech. For both the mRNA and miRNA microarray data,
background-subtracted signal-intensity expression levels for each
probe on the array were obtained and a log2 ratio comparing the
measured probe intensity for each treatment (FEN1-3, FEN1-6, and
RHA-6) to the UTC was calculated. We then applied Lowess normali-
zation to these ratios to remove any systematic bias introduced from
the independent labeling and hybridizations that were done for each
sample [13]. Measurements from replicate probes were averaged and
the resulting aggregated and normalized log2 ratios were then used
for all analysis discussed.
2.6. Immunoprecipitation
Whole cell extracts prepared in Buffer A [25 mM Tris·Cl pH8.0;
5 mM MgCl2; 150 mM KCl; 10% glycerol; 0.5 mM PMSF; 5 mM
β-mercaptoethanol; and one tablet of protease inhibitor cocktail/50 ml
(Roche)] were incubated at 4 °C for 4 h with Protein A beads (Roche)
pre-coated with antibody against Ago2 (ab57113), α-tubulin (T5168),
RIOK2 (NBP1-30098), or FEN1 (ab17993). After six washes with wash
buffer (50 mM Tris·Cl, pH7.5; 150 mM NaCl; 5 mM EDTA; 0.1% NP-40;
and 0.05% SDS), the co-selected proteins were directly separated by
loading the boiled beads into SDS-PAGE. The co-immunoprecipitated
RNAs were prepared from the beads using Tri-Reagent and subjected
to reverse transcription-qRT-PCR analysis for miRNAs or siRNAs.
2.7. Translation shut-off
HeLa cells were transfected with or without 8 nM FEN1 siRNA
for 36 h. The medium was then replaced with pre-warmed DMEM
medium supplemented with 10% FBS and 15 μg/ml cycloheximide.
Cells were collected at different times using trypsine and the protein
levels were detected by western analysis.
2.8. Pulse-chase labeling
HeLa cells grown in 15 cm plates were treated with 8 nM
FEN1 siRNA for 36 h, washed twice with PBS, and incubated with
pre-warmed medium lacking methionine (Invitrogen, RPMI 1640)
at 37 °C for 40 min. Cells were then pulse-labeled at 37 °C with
35 μCi/ml S35-methionine in the RPMI 1640 medium for 15 min,
and chased for different times by changing the medium with
DMEM medium supplemented with 1 mM unlabeled methionine.
Cells were washed with PBS containing 10 μg/ml cycloheximide and
collected using trypsine. Cells were incubated on ice for 20 min
with 500 μl lysis buffer (50 mM Tris·Cl, ph7.5; 150 mM NaCl; 2 mM
CaCl2; 1 mM PMSF; 1 tablet protease inhibitor/50 ml; and 1% Triton),
and cell lysate was cleared by centrifugation. Immunoprecipitation of
α-tubulin protein from ~75 μg whole cells extract was performed by
incubation at 4 °C for 2 h with 25 μl Protein A beads pre-coated with
~12 μg α-tubulin antibody (T5168, Sigma). After ﬁve times wash, the
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beads into SDS-PAGE, transferred to membrane, and visualized by
autoradiography.
3. Results
3.1. Transfection of different siRNAs can reduce the levels of miRNAs in
different cell types
Seven siRNAs targeting different transcripts were transfected into
HeLa cells, at a concentration of 10 nM as used in many RNAi knock-
down studies. The targeted genes were chosen to span multiple cellu-
lar processes and we also included an inactive siRNA targeting the
small nucleolar RNA U16 [12]. After 24 h, total RNA was prepared
and the levels of two abundant miRNAs, miR-16 and miR-21, were
detected by northern hybridization (Fig. 1A). The results show that
in all siRNA treated cells, the levels of the two tested miRNAs were
signiﬁcantly reduced (estimated by ~40%–80% reduction). Interestingly,
slightmiRNA reduction was also observed in cells treated with the func-
tionally inactiveU16 siRNA. Althoughwe included siRNAs targeting RHA,
TSN, and MOV10 mRNAs and these proteins have been implicated in
the function of RISC pathway [14–17], reduction of miRNAs by siRNA
transfection appears not be due to depletion of these targeted proteins
since other siRNAs targeting different proteins or even the functionally
inactive siRNA (U16 siRNA) also caused miRNA reduction.
The siRNA-induced miRNA reduction appears not unique to HeLa
cells, since transfection of 10 nM siRNAs into HEK293 or mouse
embryonic ﬁbroblast (MEF) cells also reduced the levels of miR-16
and miR-21 to different extents (Fig. 1B and C), suggesting a common
mechanism. We note that although the PTEN siRNA recognizes both
human andmouse mRNAs, MOV10 and TSN siRNAs are human speciﬁc
but still cause miRNA reduction in MEF cells, again suggesting that
the presence of a perfect siRNA target mRNA is not a prerequisite forFig. 1. Transfection of siRNAs can reduce the levels of miRNAs. Northern analyses of
miRNAs in (A) HeLa, (B) HEK293, or (C) mouse embryonic ﬁbroblast (MEF) cells treated
with different siRNAs. U16 snoRNA was detected and served as a loading control. UTC,
untreated cells transfected without siRNA.miRNA reduction. The different levels of miRNA reduction by different
siRNAs may stem from either a sequence-speciﬁc effect, or from varia-
tions in transfection efﬁciency. However, despite these variations, our
results clearly indicate that transfected siRNAs can affect miRNA levels.
3.2. Reduction of miRNAs is siRNA concentration dependent
The decreased miRNA levels may stem from siRNA competition
for RISC components, as previously proposed for siRNA-induced
mis-regulation of miRNA targets [11]. If this is the case, miRNA
reduction should depend on the siRNA concentration. To determine
this possibility and to analyze at what siRNA concentrations miRNA
reduction can occur, HeLa cells were transfected with different con-
centrations of FEN1, RHA, or PTEN siRNAs, and the effects on miRNA
levels were detected by northern hybridization (Fig. 2A). Indeed,
dose-dependent miRNA reduction was observed, as evidenced by
themoderate reduction of miR-16 andmiR-21 at low siRNA concentra-
tions (e.g., 3 nM for FEN1 and RHA siRNA, 5 nM for PTEN siRNA) but
signiﬁcant reduction at higher siRNA concentrations (6–12 nM, but
still at concentrations well below the range of 20–100 nM often used
to functionalize target genes (e.g. [18–20]). We failed to detect the
precursor of miR-16 by northern hybridization (data not shown),
due to its low abundance. However, pre-miR-21 was clearly detected
(Fig. 2A). Interestingly, the level of pre-miR-21 was not affected even
at high siRNA concentrations (12 nM for FEN1 and RHA siRNA, 30 nM
for PTEN siRNA), although the level of mature miR-21 was already
dramatically reduced in these cases. These results suggest that siRNAs
affect mature miRNAs (see below).
To further conﬁrm the dose-dependent miRNA reduction and
to determine if other miRNAs are reduced, the levels of 16 miRNAs
in FEN1 siRNA treated cells were determined using a more sensitive
approach, the TaqMan miRNA qRT-PCR assay, which only detects
mature miRNAs using speciﬁc stem-loop RNA primers (Fig. 2B).
The results show that all the 16 tested miRNAs were signiﬁcantly
reduced at low siRNA concentration (3 nM). Further, the expression
levels of the majority of miRNAs tested showed a moderately dose-
dependent reduction when cells were treated with increasing con-
centrations of siRNA. These results suggest that many miRNAs can
be affected by transfection of siRNAs, in a dose-dependent manner,
and that the effects occur in the same range of doses as those that
reduce target mRNAs.
3.3. SiRNA effects on miRNAs largely depends on Ago2
Since siRNAs and miRNAs share many RISC pathway proteins
including Dicer and Ago2, transfected siRNAs may compete with
endogenous miRNAs for these components. It has already been
reported that Ago2 is a limiting factor in the RISC pathway and that
reduction of Ago2 increased competition of different siRNAs [21–23],
suggesting that Ago2 may also play a major role in the observed
siRNA/miRNA competition. To determine if this is the case, Ago2 and
Dicer were moderately reduced by transfection of RNaseH-dependent
antisense oligonucleotides (ASOs) for 24 h, followed by transfection of
3 nM FEN1 siRNA for another 24 h, to analyze the effects on siRNA-
induced miRNA reduction. Reduction of the targeted Dicer or Ago2
protein was conﬁrmed by western analysis (Fig. 3A). Total RNA was
prepared from cell aliquots and the levels of miR-16 and miR-21 were
detected by northern hybridization (Fig. 3B). As expected, reduction
of Ago2 slightly reduced the levels of both miRNAs, consistent with
a role of Ago2 in stabilizing miRNAs [24]. In contrast, Dicer reduction
had less effect on mature miRNA levels, whereas the level of pre-
miR-21 signiﬁcantly increased, consistent with the role of Dicer in
miRNA processing and the long half-lives of mature miRNAs [25,26].
As a control, transfectionwith an ASO targeting PTEN had no signiﬁcant
effect on the levels of the two miRNAs and pre-miR-21.
Fig. 2. Reduction of miRNAs is siRNA concentration dependent. (A) Northern hybridization for miRNAs in HeLa cells treated with different concentrations of FEN1, RHA, or PTEN
siRNAs, as indicated above the lanes. U16 snoRNA was used as a loading control. The precursor of miR-21 (pre-miR-21) is indicated. (B) qRT-PCR assay for 16 different miRNAs
in FEN1 siRNA treated samples, as used in panel A. The miRNA levels were normalized to U16 snoRNA level. The error bars indicate standard deviation of three parallel experiments.
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signiﬁcantly reduced the levels of mature miR-16 andmiR-21 RNAs in
all test cells, whereas the level of pre-miR-21 was not affected in
siRNA treated cells, as compared with corresponding cells without
siRNA transfection. To determine more accurately the changes in
the levels of miRNAs in Ago2 or Dicer reduced cells upon siRNA trans-
fection, qRT-PCR approach was employed to analyze the levels of ﬁve
miRNAs (Let-7, miR-16, miR-21, miR-24, and miR-27a) (Fig. 3C).
Consistent with the northern results (Fig. 3B), stronger miRNA re-
duction was again detected by qRT-PCR assay in the Ago2 reduced
cells than the Dicer reduced cells without siRNA transfection. Upon
siRNA transfection, the miRNA levels were reduced in all test cells,
as expected. Importantly, the tested miRNAs exhibited lower levels
in the Ago2 reduced cells than in the control cells or in the Dicer
reduced cells. On the contrary, the miRNA levels in the Dicer reduced
cells were largely comparable with that in the control cells upon
siRNA transfection. Together, these data suggest that siRNAs compete
with miRNAs mostly for Ago2, but not Dicer. This view is supported
by the observations that siRNA transfection did not affect miRNA
processing, and that miRNA processing factors, including Dicer, are
not limiting, since reducing Dicer caused accumulation of pre-miRNAs
([27] and Fig. 3B).
3.4. Competition of siRNAs with miRNAs occurs shortly after
siRNA transfection
It has been demonstrated that siRNAs can trigger target mRNA
degradation within 4 h after transfection [21], suggesting that shortly
after transfection, siRNAs can bind Ago2 and to be effective. In thiscase, miRNA levels should also be affected quickly after siRNA trans-
fection. To determine the kinetics of siRNA effects on miRNA levels,
HeLa cells were transfected with 10 nM PTEN siRNA for different
times, and the levels of seven miRNAs were detected using qRT-PCR.
PTEN siRNA was chosen for this purpose because this gene is not impli-
cated in the metabolism of nucleic acids, simplifying interpretations.
Indeed, the levels of two tested miRNAs, miR-17 and miR-378,
were quickly reduced after siRNA transfection, even at early time points
(2–4 h) (Fig. 4A). This is consistent with previous observations that
targetedmRNAs could be signiﬁcantly reduced 2 h after siRNA transfec-
tion [21], suggesting that siRNAs rapidly compete with some miRNAs
for Ago2 binding, leading to reduction of those miRNAs that otherwise
are protected by Ago2 protein.
Surprisingly, ﬁve (miR-16, miR-21, miR-24, miR-27a, and miR-
542) of the seven tested miRNAs exhibited a different pattern of
changes in the cellular levels in response to siRNA transfection. In
these cases, the miRNA levels were ﬁrst moderately increased shortly
after siRNA transfection (2–4 h), and then decreased at later time
points (6–8 h) (Fig. 4B). The transient increase of miRNA levels
upon siRNA transfection raises an interesting possibility that some
miRNAs, once being competed out from RISC by siRNAs, could be
initially protected by other proteins. If this is the case, the levels of
Ago2-bound miRNAs should be quickly reduced upon siRNA transfec-
tion. Indeed, although the total cellular levels of miR-16 and miR-21
slightly increased at 2–4 h upon siRNA transfection, the levels of
Ago2-bound miRNAs were signiﬁcantly reduced at these time points,
as determined using RNA-immunoprecipitation with an Ago2 anti-
body followed by qRT-PCR analysis for three miRNAs (Fig. 4C).
An even more profound decrease in the level of Ago2-bound
Fig. 3. siRNA-induced miRNA reduction is Ago2 dependent. (A) Western analysis for the levels of Dicer and Ago2 in HeLa cells treated with ASOs. γ-tubulin was used as a loading
control. (B) Northern analysis of miR-16 and miR-21 in cells depleted of different proteins with or without transfection of FEN1 siRNA. U16 snoRNA serves as a loading control.
(C) qRT-PCR for the levels of ﬁve miRNAs in control (UTC), Ago2 reduced [(−)Ago2], and Dicer reduced [(−)Dicer] cells transfected with [(+)siRNA] or without [(−)siRNA]
FEN1 siRNA transfection, as used in panel B. The error bars indicate standard deviation of three parallel experiments.
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portion of miR-378 dissociated from Ago2. Importantly, the reduction
of Ago2-bound miRNAs was accompanied by an increase in the levels
of Ago2-bound siRNAs over time after transfection (Fig. 4D), supporting
the view that siRNAs compete with some miRNAs for Ago2, leading
to eventual reduction of these miRNAs. Note that the reduction of
Ago2-bound miRNAs was not due to unexpected reduction of Ago2
protein, since the Ago2 level was actually up-regulated shortly after
siRNA transfection (Fig. 4E). Taken together, these results indicate
that transfection of siRNAs can quickly compete for Ago2 with miRNAs,
leading to rapid reduction of some Ago2-bound miRNAs.
3.5. Transfection of siRNA can alter the levels of many miRNAs
Next, we analyzed if siRNA transfection can affect miRNA levels at
a global level. For this purpose, HeLa cells were treated for 24 h with
FEN1 siRNA at 3 or 6 nM, or RHA siRNA at 6 nM. Total RNA was
prepared and subjected to hybridization-based microarray analysis
for 1884 different miRNA species. Although the majority of the
microRNA species measured on the microarray showed no signiﬁcant
change,manymiRNAswere seen to be reduced signiﬁcantly after siRNA
treatment (Fig. 5A, left end, and Supplemental Table 1). Interestingly, a
small number of miRNAs appeared to be increased (Fig. 5A, right end).
These observations suggest that different miRNAs can be differentially
affected by siRNA transfection.
Of the 167 miRNAs observed to change by more than one-fold by
either of the siRNA treatments, 69 were repressed in both FEN1 andRHA siRNA treated samples, suggesting that such a reduction is
not siRNA sequence-speciﬁc. Previous work demonstrated that the
majority of the miRNA mass in HeLa cells is accounted for by only a
few miRNA species [11]. Indeed, the majority of miRNA species, espe-
cially those that showed no signiﬁcant level changes in siRNA treated
cells, were poorly expressed (Fig. 5B, middle portion). Remarkably we
found that the 69 repressed miRNAs included 7 of the 10 previously
reported miRNAs that were ascribed to account for over 75% of the
total miRNA mass in HeLa cells (Fig. 5C and Supplemental Table 1).
In addition, 24 miRNAs appeared to be up-regulated in both siRNA
treated samples. Interestingly, the hybridization signal strength is
higher for the signiﬁcantly changed miRNAs (Fig. 5B, both right and
left ends), suggesting that these miRNAs are expressed at high levels,
or that cross-hybridization to pre-miRNAs may contribute to the
signal strength, especially for those miRNAs with abundant precursors
(see below).
Since most unchanged miRNA species in the microarray analyses
exhibited weak hybridization signals (Fig 5B, middle portion), it is pos-
sible that the levels of someof thesemiRNAsmay actually have changed
but the change was not detected by microarray hybridization due to
low signal strength. To determine if this is true, and to conﬁrm reduc-
tion or up-regulation of those miRNAs detected by microarray analysis,
we examined the levels of 20 miRNA species in the same RNA samples
using mature miRNA speciﬁc qRT-PCR assay, which is more sensitive
than probe-based microarray analysis [28]. These include six down-
regulated miRNAs (more than one-fold reduction), 13 miRNAs that
displayed no signiﬁcant change (−1 to +1-fold), and one miRNA
Fig. 4. Rapid competition of siRNA and miRNA for Ago2 binding. HeLa cells were transfected with PTEN siRNA for different times, and total RNA was prepared. Endogenous miRNA
levels were determined by qRT-PCR and normalized to U16 snoRNA level. Two patterns of level changes were observed. (A) miRNAs that quickly reduced upon siRNA transfection.
(B) miRNAs that increased shortly after siRNA transfection, followed by reduction over time. (C) The levels of Ago2-associated miRNAs quickly decreased after siRNA transfection.
Ago2-bound miRNAs were isolated by immunoprecipitation from cells as used in Panel A, and co-selected miRNAs were analyzed by qRT-PCR. Con. control immunoprecipitation
with a FEN1 antibody, using mixed extracts pooled from equal amount of materials from different time points. (D) The same co-precipitated RNA samples as used in panel C were
analyzed for the level of co-selected PTEN antisense siRNA using qRT-PCR. (E) Ago2 protein is up-regulated in siRNA treated cells. Aliquots of whole cell extract as used in panel C
were analyzed by western analysis for the levels of Ago2. γ-tubulin was used as a loading control. A non-speciﬁc product detected by Ago2 antibody is marked with an asterisk.
The error bars represent standard deviation from three parallel experiments in all panels where applied.
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was again detected in qRT-PCR assay for the six down-regulated
miRNAs (Fig. 5D, the left-most six miRNAs), consistent with the micro-
array results and with the results in Fig. 2B. For the 13 miRNAs that did
not show signiﬁcant reduction in the microarray analysis, ten were
found by qRT-PCR assay to be reduced by about one-fold in at least
one siRNA treated sample (Fig. 5D), indicating that many “unchanged”
miRNAs were actually reduced in siRNA treated cells.
Interestingly, three miRNAs (miR-202-3p, miR-720, and miR-1246)
were again found in qRT-PCR assay to have been unchanged and one
miRNA (miR-3196) had elevated levels in siRNA treated cells (Fig. 5D,
right panel), implying that miRNAs can be differentially affected.
To determine if these miRNAs were protected by other means upon
siRNA transfection, immunoprecipitation was performed using the
Ago2 antibody and co-selected miRNAs were analyzed by qRT-PCR
(Fig. 6A). Indeed, it appeared that miR-202, which exhibited unchanged
or elevated levels in siRNA treated cells (Fig. 5D), was probably stabilized
by other proteins in FEN1 siRNA treated cells, since immunoprecipitation
with Ago2 only recovered ~2% of thismiRNA in FEN1 siRNA treated cells,
as compared with ~13% recovery in control cells. In contrast, the recov-
ery rates for most other miRNAs were more than 15% in both control
and siRNA treated cells (Fig. 6A). Note that the recovery rate for different
miRNAs using the Ago2 antibody was different, consistent with a recent
report which showed different co-depletion efﬁciencies for different
miRNAs using a Pan-Ago antibody [29], suggesting that the proportion
of Ago2-bound miRNAs can vary for different miRNAs (see Discussion).Surprisingly, the recovery rates for miR-720, miR-1246, and
miR-3196 were extremely low, ranging from 0.1% to 1.8%, even in
control cells (Fig. 6A, right panel). These results suggest that large
portion of this set of RNAs detected in microarray or qRT-PCR do
not bind Ago2. It is possible that the microarray signals for these
miRNAs may be due to hybridization to abundant precursors, since
some, but not all, miRNAs can have abundant precursors [30,31].
Indeed, northern hybridization results showed that the probes speciﬁc
to the three above-mentioned miRNAs and another miRNA (miR-
1260a)which all showed high signal intensity in themicroarray strongly
hybridized to some larger RNA species (40–250 nt), most likely precur-
sors of the miRNAs (Fig. 6B). Signiﬁcant reduction was detected for the
maturemiRNAmiR-1260a, however, no signiﬁcant changewas observed
for mature miR-720 and miR-1246 that were poorly expressed, indicat-
ing that the levels of somemiRNAs, especially those that do not strongly
associate with Ago2, were not affected by siRNA transfection. Consistent
with Fig. 2A, transfection of siRNAs did not affect the levels of these
miRNA precursors, again indicating that miRNA processing was not
affected. We note that cross-hybridization occurred with the miR-3196
probe to an RNA(s) that is too large to enter the well, thus the hybridiza-
tion signal strength for this RNA(s) did not represent the actual level of
the RNA(s), which may increase in siRNA treated cells as detected in
the microarray assay. Since we failed to detect the mature miR-3196
by northern hybridization, we cannot exclude the possibility that this
miRNA, and probably other miRNAs as well, were increased upon
siRNA transfection, due to unknownmechanisms or that these registered
Fig. 5. Transfection of siRNAs can alter the levels of many endogenous miRNAs. (A) Relative expression levels of miRNAs in HeLa cells treated with different siRNAs as detected using
microarray analysis were shown in log2 ratio relative to control cells, and sorted by the measurements from the 6 nM FEN1 siRNA treated cells. The X-axis indicates the numbers of
miRNA species. (B) The signal intensity of the same miRNAs as ordered in panel A in microarray analysis. The log2 ratio relative to control cells is shown. (C) Heat map of the
miRNAs observed to have more than one-fold reduction after treatment with either 6 nM FEN1 or 6 nM RHA siRNA within the normalized microarray data. The log2 ratio relative
to control cells is shown on a colorimetric scale in left panel and the log2 signal intensity for each miRNAs in control cells (UTC) on an independent colorimetric scale is shown on
the right. (D) qRT-PCR results for miRNAs in the same RNA samples used in microarray assay, and normalized to U16 snoRNA. The error bars indicate standard deviation from three
parallel experiments.
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Fig. 6. The microarray signal intensity of some miRNAs may come from precursor RNAs. (A) Recovery rates of miRNAs co-precipitated with Ago2 from control or siRNA treated cells.
miRNA levels in input and precipitated materials were detected by qRT-PCR, calculated, and plotted. The error bars indicate standard deviation of three parallel experiments.
(B) Northern analysis for four representative miRNAs that exhibited high signal strength in the microarray analysis. U16 was used as a loading control. The mature miRNAs
or the predicted positions are indicated. Cross-hybridized products are marked with asterisks. Shorter exposure image is shown in the lower panels. The size markers in nts
were determined based on the positions of 5S rRNA and miR-21 RNA.
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clearly indicate that the levels of many miRNAs were affected by siRNA
transfection, and that miRNAs that are strongly associated with Ago2
are particularly likely to be reduced.
3.6. Transfection of siRNAs can affect mRNA expression in a siRNA
concentration dependent manner
Previous studies have shown that transfection of siRNAs can affect
the expression of many genes, likely due to off-target effects that can
non-speciﬁcally reduce the expression levels of non-targeted genes, or
due to interferon response or transfection-related effects [7,32–34]. In
addition, since miRNAs can negatively regulate gene expression mainly
by reducing target mRNA levels [35], reduction of miRNAs by siRNA
transfection may thus cause up-regulation of the miRNA target genes.
To support this view, a recent study showed that targets of endogenous
miRNAs were expressed at signiﬁcantly higher levels after transfection
of different siRNAs or miRNAs, by analyzing 151 published transfection
experiments [11]. Since in many experiments analyzed in that study
the siRNA concentrations used (10–100 nM) were much higher than
what we employed here (3–6 nM), we next analyzed by microarray
assay if expression of protein coding genes were affected under these
conditions, using the same RNA samples for miRNA microarray assay.
Reduction of the targeted FEN1 and RHA mRNAs was conﬁrmed byqRT-PCR (data not shown). Consistent with previous studies [36],
expression of many genes were down-regulated upon transfection of
3–6 nM siRNAs (Fig. 7A and Supplemental Table 2), likely due to off-
target effects. As expected, a number of genes were also up-regulated
under these conditions. For the genes with statistically signiﬁcant
microarray values (P value b0.01), ~44%, 38%, and 55% of genes appear
to be up-regulated in cells treated with 3 or 6 nM FEN1 siRNA, or
with 6 nM RHA siRNA, respectively, as compared with control cells
transfected without siRNA (Fig. 7A). In addition, up-regulation of several
known miRNA targeted genes (e.g., CCND1, DUSP2, DUSP4, TNRC6,
YOD1, and ATF3) that were reported in a previous study to be up-
regulated was also observed in all siRNA treated cells in this study
([11] and Supplemental Table 2), suggesting a general mechanism.
The altered gene expression proﬁle appears to be an effect of siRNA
transfection, since the extent of level changes in gene expression is
siRNA dose-dependent. This can be clearly seen for cells treated with
3 and 6 nM FEN1 siRNA (Fig. 7B). For both up- and down-regulated
genes, greater changes were found for cells treated with higher siRNA
concentration, suggesting that most of these changes were not due
to loss of the targeted protein, since with these siRNA concentrations
the FEN1 protein was already dramatically reduced (see below).
To further support the view that miRNA destabilization can result
in target gene up-regulation, we compared the gene expression
changes observed within the collection of mRNAs that contain
Fig. 7. Expression of many genes was altered in siRNA treated cells. (A) The number of genes that were signiﬁcantly changed in siRNA treated cells, as detected in microarray analysis.
The P-value threshold was 0.01. (B) Dose-dependent effect of gene expression in cells treated with different concentrations of FEN1 siRNA. The Log2 ratio relative to control cells
(UTC) was sorted based on the FEN1-6 sample (red), and the measurements from the FEN1-3 sample was shown in green. The trend line for both samples was drawn based on a sliding
mean across the data using a window of 100 genes. The X-axis indicates the number of genes. (C) Two overlapping histograms are shown which highlight the signiﬁcant enrichment of
slightly up-regulated geneswithin a collection of repressedmiRNA target genes. In blue is a histogram showing the observed distribution of all the log2 ratiosmeasured on the array from
the RHA-6 sample. Superimposed in green is the observed distribution for only genes predicted to be targets of the top 20 most down-regulated miRNAs.
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TargetScan algorithm. As shown in Fig. 7C, there is a slight, but signiﬁ-
cant, trend indicating that targets of highly repressed miRNAs have
increased expression. These results are consistent with the idea that
up-regulation of certain gene(s) by siRNA transfection stems from
reduced levels of endogenous miRNAs.
3.7. siRNA transfection increased the levels of GZMB and GZMM and
reduced the level of α-tubulin protein
It is well known that transfection of siRNAs can cause off-target
effects. However, the consequences of such effects are not well studied.
Since transfection of siRNAs can cause up-regulation of many miRNA
target genes due to reduction in the levels of many miRNAs, we
reasoned that such mis-up-regulation may lead to subsequent effects
even at protein level. To evaluate this hypothesis, we sought to deter-
mine if the expression of some proteases containing miRNA target
sites is up-regulated upon siRNA transfection, and if so, whether
the target proteins are non-speciﬁcally degraded. For this purpose,
we focus on Granzyme B and Granzyme M, two proteases known to
degrade α-tubulin [37,38]. The 3′ UTR region of the GZMB and GZMM
mRNAs can be potentially targeted by nine and 11miRNAs, respectively(Fig. 8A), as predicted using TargetScan (http://www.targetscan.org).
Among the 20 predicted miRNAs, 10 were reduced as observed in
miRNA microarray and/or qRT-PCR assay, 10 did not exhibit signiﬁcant
change in microarray analysis for FEN1 or RHA siRNA treated cells
(Supplemental Table 1 and Fig. 5).
Since GZMB and GZMM are expressed at very low levels and were
not convincingly detected in microarray analysis, we analyzed the
mRNA levels by qRT-PCR assay. HeLa cells were transfected with a
slightly higher dose of FEN1 siRNA (8 nM), to enhance possible
changes in the levels of the mRNAs and/or proteins of these proteases.
In siRNA treated cells, the GZMB and GZMM mRNAs were increased
by ~30% and ~110%, respectively (Fig. 8B). We failed to detect the
GZMB protein by western analysis using three different antibodies,
most likely due to low expression levels. However, the protein level
of GZMM, although being low, was detected to be signiﬁcantly
increased upon siRNA transfection (Fig. 8C). These results indicate
that siRNA transfection leads to up-regulation of GZMB and/or
GZMM, like many other genes.
Next, we determined if siRNA transfection reduced the level of
α-tubulin protein, a substrate of the two proteases. HeLa cells were
treated with FEN1 siRNA for 48 h at different concentrations, and
α-tubulin levels were detected by western analysis (Fig. 8D). Indeed,
Fig. 8. siRNA transfection can cause up-regulation of GZMB and GZMM proteins but reduction of α-tubulin protein. (A) Schematic depiction of miRNAs potentially targeting GZMB
and GZMM 3′ UTR regions. The relative positions of miRNAs are indicated with color bars, and names are shown with the corresponding colors. The gray box indicates the coding
region of the mRNAs. (B) The levels of GZMB and GZMMmRNAs increased in HeLa cells treated with 8 nM FEN1 siRNA, as determined by qRT-PCR. The error bars indicate standard
deviation from three parallel experiments. (C) GZMM protein level increased in HeLa cells treated with FEN1 siRNA. hnRNP A2 was used as a loading control. (D) Western analysis
for α-tubulin protein in HeLa cells treated with different concentrations of FEN1 siRNA. Reduction of the targeted FEN1 protein was conﬁrmed. γ-tubulin serves as a loading control.
(E) Western analyses of α-tubulin protein in HeLa cells treated for 48 h with 5 nM of different siRNAs, as performed in panel E. hnRNP A2 and γ-tubulin were detected and used as
loading controls.
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FEN1 siRNA, as detected with short exposure time in western analysis
to avoid saturation of the signal. Importantly, α-tubulin reduction is
siRNA dose-dependent, as slight to moderate reduction was observed
at lower siRNA concentrations. In addition, reduction of α-tubulin
protein was not due to loss of FEN1, since signiﬁcant reduction of
FEN1 protein was already achieved at low siRNA concentrations and
other siRNAs (see below) produced similar effects. Note that the γ-
tubulin level was not signiﬁcantly changed, suggesting that not all
microtubule-related proteins are equally affected by siRNA transfec-
tion. α-tubulin reduction appears to be a general effect of siRNA
transfection, since transfection of 5 nM of different siRNAs targeting
eight different genes in HeLa cells all caused reduction of α-tubulin
protein, to different extents (Fig. 8E). Together, these results indicate
that transfection of different siRNAs can non-speciﬁcally reduce
the level of α-tubulin protein, a substrate of the two proteases
(GRMB and GZMM) which are up-regulated after siRNA transfection.
Moreover, these effects are observed at siRNA doses near the dose
at which the target mRNAs of these siRNAs were reduced and far
below the concentrations that are often used to functionalize genes
(e.g., [20,39]).3.8. Reduction of α-tubulin is due to rapid degradation at the protein level
siRNA induced reduction of α-tubulin protein could be a result
of several mechanisms. It is possible that some siRNAs can cause
off-target effects by non-speciﬁc cleavage of α-tubulin mRNA.
However, that appears not the case, because the mRNA level of
α-tubulin was not signiﬁcantly reduced in siRNA-transfected cells
(Supplemental Fig. S1A), suggesting that transcription and the RNA
stability were not affected. In addition, it is also unlikely that this is
an effect of the dsRNA-induced immune response, which can cause
global reduction of translation or mRNA levels [7], since 1) translation
of α-tubulin was not affected (see below); 2) siRNA did not cause
α-tubulin reduction without transfection (Supplemental Fig. S1B),
which would be expected if the effect was secondary to a dsRNA-
induced interferon response [40]; and 3) the mRNA level of OAS1, an
interferon response marker gene, was not signiﬁcantly up-regulated
(Supplemental Fig. S1C), whereas during the interferon response, the
OAS1 mRNA level is expected to increase by more than 50-fold [41].
To determine if reduction of the α-tubulin protein in siRNA treated
cells resulted from impaired translation or protein stability, pulse-
chase labeling was performed using S35-methionine. α-tubulin protein
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body, to avoid saturation of co-precipitation. In siRNA treated cells,
the signal strength of newly synthesized α-tubulin was comparable to
control cells at early time points of chase (0–2 h) (Fig. 9A), indicating
that translation of α-tubulin was not signiﬁcantly impaired by siRNA
transfection, consistent with the unchanged level of α-tubulin mRNA.
However, the levels of newly produced α-tubulin protein in siRNA-
transfected cells was signiﬁcantly reduced (~50%) 4–6 h after onset of
chase, as compared with time point 0, whereas in the control cells, the
levels of α-tubulin protein remained unchanged during 6 h of chase
(Fig. 9A). These results indicate that the newly produced α-tubulin
protein is less stable in siRNA treated cells than control cells.
The reduced stability was further conﬁrmed by determining the
half-life of α-tubulin. Control or siRNA-transfected HeLa cells were
treated for different times with cycloheximide to arrest translation,
and protein levels were detected by western analysis. The half-life
of α-tubulin was greater than 24 h in control cells, consistent with
previous reports [42], whereas in siRNA treated cells which exhibited
reduced levels of the protein, the half-life was much shorter, estimated
at ~10 h (Fig. 9B). In addition, we determined if α-tubulin reduction
kinetically correlated with miRNA reduction. Consistent with the
rapid reduction of Ago2-associated miRNAs after siRNA transfection,
reduction of the steady state level of α-tubulin was observed within
~3–6 h after transfection (Fig. 9C).
Next, we investigated by immunoprecipitation whether siRNAs
directly interact with α-tubulin protein, since it has been shown thatFig. 9. Reduction of α-tubulin is due to faster degradation of the protein. (A) Translation of α
siRNA were pulse-labeled and chased for different times as indicated. α-tubulin protein was
alized by autoradiography. As a control, 10% of immunoprecipitation input material was ana
(B) The half-life of α-tubulin is reduced in siRNA treated cells. HeLa cells transfected with or
above lanes. The protein level was detected by western analysis. A duplicate gel was stained
(C) α-tubulin reduction is a quick response to siRNA transfection. HeLa cells were transfecte
western analysis. GAPDHwas used as a loading control. (D) Reduction of Ago2 caused strong
in Fig. 3B were analyzed by western analysis for α-tubulin. γ-tubulin was used as a loa
siRNA-induced tubulin reduction. HeLa cells were transfected with 0.75 nM siRNAs targ
co-depletion. After 36 h, 8nM FEN1 siRNA was transfected. Cells were harvested 16 h latersome microtubule-targeting reagents can lead to rapid degradation of
tubulin by directly interacting with tubulin protein or microtubules
[42,43]. Neither sense nor antisense siRNA was signiﬁcantly co-
precipitated with α-tubulin protein (Supplemental Fig. S2A). As a
positive control, siRNAs were signiﬁcantly co-precipitated with Ago2.
Additionally, neither α- nor β-tubulin protein could be co-selected
with Ago2 protein (Supplemental Fig. S2B), suggesting that α-tubulin
reduction is not induced by direct interaction with siRNAs and/or
Ago2 protein.
Since siRNA-induced miRNA reduction depends on Ago2, but
not Dicer (Fig. 4), we analyzed if this is also the case for α-tubulin
reduction. The level of α-tubulin protein in the same Ago2 or
Dicer-depleted cells as used in Fig. 3 was analyzed by western analy-
sis (Fig. 9D). No signiﬁcant reduction of α-tubulin was observed in
cells moderately depleted of Ago2 or Dicer without siRNA treatment,
consistent with the minor reduction of miRNA levels in these cells.
However, transfection of siRNA caused signiﬁcant reduction of α-
tubulin protein in all test cells. Whereas similar reduction was found in
Dicer or PTEN depleted cells, as compared with control cells, a stronger
reduction was observed in Ago2 depleted cells. These results support
the notion that siRNA-induced α-tubulin reduction depends on Ago2,
and that Dicer depletion had no signiﬁcant effect onα-tubulin reduction,
again consistent with the siRNA effects on miRNAs.
Finally, we analyzed if GZMB and GZMM are involved in the siRNA-
induced α-tubulin reduction. The two proteases were depleted by
transfection of speciﬁc siRNAs at low concentration, either individually-tubulin is not affected by siRNA transfection. HeLa cells treated or not with 8 nM FEN1
immunoprecipitated and separated by SDS-PAGE, transferred to membrane, and visu-
lyzed on another gel and stained with coomassie blue, as indicated in the lower panel.
without FEN1 siRNAs were treated with cycloheximide for different times, as indicated
with coomassie blue and served as a loading control (lower panel). UTC, untreated cells.
d with 10 nM FEN1 siRNA, collected at different times, and α-tubulin level analyzed by
er siRNA-induced α-tubulin reduction. Whole cell extracts from aliquots of cells as used
ding control. (E) Simultaneous reduction of GZMB and GZMM partially suppressed
eting U16, GZMB, or GZMM alone, or 0.5 nM each of GZMB and GZMM siRNAs for
and protein levels were detected by western analysis.
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proteases play redundant roles. The effect of reducing these proteases
on α-tubulin reduction was analyzed by transfection of 8 nM FEN1
siRNA, and the tubulin level was detected by western analysis (Fig. 9E).
Although the GZMB and GZMM mRNAs were reduced by more than
80% in cells treated with corresponding siRNAs individually or in combi-
nation (data not shown), reduction of either GZMB or GZMM had no
signiﬁcant effect on α-tubulin reduction, similar to the case in control
siRNA (U16) treated cells. However, co-depletion of the two proteases
partially restored α-tubulin level, suggesting that GZMB and GZMM
may have redundant roles in α-tubulin degradation, and that siRNA-
induced tubulin reduction is at least partially due to up-regulation of
the two proteases. Altogether, these results indicate that transfection of
siRNAs can induce rapid degradation of α-tubulin at the protein level,
most likely due to reduction in the levels of some miRNAs that in turn
leads to up-regulation of some proteases.
4. Discussion
Transfection of siRNAs or miRNAs has been shown to be able to
saturate the endogenous RISC components, leading to mis-regulation
of miRNA targets [11]. In this study, we determined by northern,micro-
array, and qRT-PCR assays that transfection of siRNAs can alter the
expression levels of many miRNAs, with highly expressed miRNAs
being preferentially reduced. Although exogenous siRNAs may also
compete for upstream proteins required for miRNA processing, such
as Dicer or DGCR8, our data support the possibility that siRNAs mainly
compete with mature miRNAs for Ago2. The evidence for this includes:
1) reduction of Ago2, but not Dicer, enhanced siRNA/miRNA competi-
tion, 2) siRNA transfection reduced the level of many mature miRNAs,
but pre-miRNA levels were not affected even at high tested siRNA con-
centrations, and 3) siRNA/miRNA competition occurred at very early
time points (2–4 h after transfection), leading to reduction of cellular
miRNA levels 24 h after siRNA transfection, whereas the average
half-life of miRNAs can be ~119 h [26]. These observations suggest
that transfection of siRNAs can quickly reduce the levels of Ago2-
boundmature miRNAs by competition for Ago2, leading to disassembly
of miRNAs from RISC, and ultimately causing reduction of steady state
levels of miRNAs. However, we cannot rule out the possibility that
processing of certain miRNAs could be affected by siRNA transfection,
as production of some miRNAs requires Ago2 [44,45]. The fact that
different siRNAs showed different potencies for the competition for
Ago2 with miRNAs suggests that different siRNAs may have different
afﬁnities for Ago2 protein. This is consistent with previous reports
that different siRNAs compete more or less favorably with each other
[21] and the observation that the IC50 for siRNA-mediated reduction
of target mRNA correlates with the ability to compete with miRNAs
for Ago2. All of these are consistent with the notion that Ago2 con-
centrations are limiting and Ago2 interacts differentially with different
guide strand sequences.
The rapid loss of miRNAs after siRNA transfection is interesting.
It has been shown that miRNAs are stable RNAs and Ago2 is required
for the stability of miRNAs [24,26], implying that miRNAs stably
bind Ago2 protein. However, in our study, we found that shortly
after siRNA transfection, the levels of Ago2-associated miRNAs were
reduced, suggesting that miRNAs can be replaced by siRNAs from
the RISC complex due to different afﬁnity to RISC components
such as Ago2, or that miRNAs and siRNAs can compete for Ago2 in a
dynamic way. This latter view is supported by a recent study showing
that in HeLa cells miRNAs are expressed in a 13-fold excess relative to
Ago proteins and that miRNAs are bound to mRNAs in a 7-fold excess
relative to Agos [29]. These ﬁndings suggest that not all miRNAs or all
miRNA/mRNA duplexes bind Ago proteins. Therefore it is possible
that miRNAs can dynamically associate with Ago proteins. Our view
is that in cells miRNAs are in equilibrium with some binding proteins
and siRNAs may compete for binding of miRNAs to multiple proteinsincluding Ago2. Obviously, the consequence of Ago2 competition is
physiologically important and is the subject of this investigation.
Nevertheless, the rapid loss of miRNAs suggests that the siRNAs
may also displace the miRNAs from other stabilizing proteins as the
Ago2 accounts for only a fraction of total miRNA binding. The physio-
logical consequence of siRNA/miRNA competition at non-Ago2 sites
remains to be evaluated.
Our results showed that siRNA competition could occur even at low
siRNA concentrations, such as 3–6 nM (Figs. 2 and 3). To understand
quantitatively the siRNA/miRNA competition, we measured the PTEN
siRNA copynumberswhen transfected at 3 or 6 nMﬁnal concentrations
for 24 h. The siRNA copy numbers per cell were 807.1×103±72.9×103
and 1091.6×103±173.07×103 in cells transfected with 3 or 6 nM
siRNAs, respectively (data not shown). Under these conditions, the
siRNA copy numbers are 3–4-fold higher than cellularmiRNA numbers,
since the total numbers of detectable miRNAs in HeLa cells has been
measured to be 202,765 per cell [29]. Thus, it is not surprising that
siRNAs can quickly compete with endogenous miRNAs even at “low”
siRNA concentrations. It is also entirely sensible that competition occurs
at pharmacologically active siRNAs as the mechanism requires binding
to Ago2.
Our microarray and qRT-PCR data indicate that many miRNAs
were down-regulated by siRNA transfection, especially those highly
expressed miRNAs, most likely by competition for Ago2 binding.
However, no signiﬁcant change was detected for most of the miRNA
species bymicroarray analysis and a small number of miRNAs appeared
increased. Several possibilities exist for this complex situation, for
example: 1) some miRNAs may have high afﬁnity to Ago2, thus it is
difﬁcult for siRNAs to compete; and 2) some miRNAs may bind to
other proteins rather than Ago2, as illustrated by immunoprecipitation
analysis (Fig. 6). To support this view, it has been shown that the ex-
pression levels of miRNAs were reduced but not completely inhibited
in Ago2 knockout cells [46]. In addition, a recent study also showed
that the copy numbers of 669 detectable miRNAs and the four Ago
proteins in HeLa cells were determined to be ~202,765 and 15,000 per
cell, respectively [29]. These observations suggest that many miRNA
molecules donot bindAgo2, therefore theymaynot be strongly affected
by siRNA transfection; 3) changes of some miRNAs were not detected
by microarray assay due to low expression levels and limitations of
the approach, as demonstrated by qRT-PCR analysis which showed
that some “unchanged” miRNAs were actually reduced (Fig. 5D);
4) strong signals from cross-hybridization to precursors may mask
the actual levels on some mature miRNAs, especially those miRNAs
with abundant precursors, as determined by northern hybridization
(Fig. 6B); and 5) some registered miRNAs that were included in the mi-
croarray assay may not be bona ﬁde miRNAs. Despite this complexity,
our results clearly showed that many miRNAs could be reduced
by siRNA transfection in different cell types, especially the abundant
miRNAs. Consistent with our observation, it has been shown that
injection of siRNAs in zebraﬁsh embryos caused signiﬁcant reduction of
miR-430 and a few other tested miRNAs [47], indicating that this
phenomenon also applies to other organisms.
Reduced levels of miRNAs by expression of shRNAs have been
reported [8,9]; however, administration of synthesized siRNAs in
mice did not reduce the level of miRNAs [10]. This discrepancy was
explained as a result of competition for Exportin-5 between shRNAs
and pre-miRNAs during processing [8], whereas synthesized siRNAs
do not require further processing. However, siRNAs can compete
with miRNAs for Ago2, the core protein component of the RISC
complex, leading to reduced miRNA levels, as we demonstrated in this
study. The difference between our in vitro study and the previously
reported in vivo study [10] may stem from either sequence-dependent
effects, or from difference in the cellular siRNA concentrations
obtained after in vitro transfection and in vivo administration. In
addition, we cannot exclude the possibility that the regulation of
the RISC pathway may differ between in vivo and in vitro systems.
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genes can be regulated by miRNAs [5]. Thus altered levels of many
miRNAs after siRNA transfection can change the expression of many
genes, leading to unexpected consequences. In principal, reduction
of miRNAs may cause up-regulation of miRNA target genes, however,
majority of the mRNAs were not signiﬁcantly up-regulated and some
were even down-regulated. This complexity can be explained by
the fact that miRNA-mediated regulation is only to ﬁne-tune gene
expression and is only one of many regulation pathways. Nonspeciﬁc
reduction of many genes due to off-target effects or interferon responses
of siRNA treatment has already been well documented [7,32,48], so it
will not be further discussed here. The complex regulation of gene
expressionmay explainwhymany other proteins, including the proteins
used as loading control in this study, were not affected by siRNA trans-
fection. Featured in this study is that reduced levels of many miRNAs
by competition with siRNAs can cause up-regulation of many miRNA
targeted genes, which in turn can lead to unexpected effects. Indeed,
a number of genes were up-regulated upon siRNA transfection, as
determined by microarray analysis (Fig. 7). Importantly, the genes
targeted by the top 20 mostly repressed miRNAs were preferentially
up-regulated (Fig. 7C). This observation is consistent with a previous
study which showed that transfection of siRNAs or miRNAs caused
up-regulation of a large number of genes [11], especially miRNA-target
genes. Among the up-regulated genes, important to this study
are GZMB and GZMM, the two proteases known to be involved in
α-tubulin degradation. To support the view that these two enzymes
are involved in siRNA-induced α-tubulin reduction, we showed that
simultaneous reduction of GZMB and GZMM, but not individually,
partially rescued the accumulation of α-tubulin protein, suggesting
that the two proteases are involved and have redundant roles in
α-tubulin degradation. These observations imply a potential mecha-
nism for siRNA-induced α-tubulin reduction: siRNA transfection
reduces, by competition for Ago2, the levels of many endogenous
miRNAs, leading to up-regulation of many miRNA target genes includ-
ing GZMB and GZMM, which in turn causes rapid degradation of
α-tubulin protein. However, we cannot exclude the possibilities that
other pathways may exist to induce or activate expression of GZMB
and GZMM, for example, by mis-regulation of other proteins required
for regulation of these two proteases, and that other factors that can
also degrade α-tubulin protein were up-regulated as well.
Reduction ofα-tubulin is a rapid response to siRNA transfection that
occurs ~3–6 h after siRNA transfection (Fig. 9C), suggesting that reduc-
tion of α-tubulin involves degradation of pre-existing protein, since
the half-life of α-tubulin is over 24 h (Fig. 9B). Indeed, the stability
of the protein was signiﬁcantly impaired by siRNA transfection, as
demonstrated by pulse-chase labeling assay. Interestingly, in many
siRNA-mediated knockdown studies, α-tubulin protein was commonly
used as a loading control to demonstrate sequence-speciﬁc target
reduction in western analyses. Our observations that siRNAs induced
α-tubulin reduction raise this question: why in other studies was
reduction of α-tubulin not reported or observed? Several possibilities
exist for this situation, for example, 1) the effect may depend on
siRNA transfection efﬁciency, it may not be obvious in all experiments;
2) as α-tubulin is a highly abundant protein, over-loading or over-
saturated exposure during western assay may easily mask the differ-
ence of tubulin levels; and 3) reduction of α-tubulin might be ignored
if the effect is not dramatic. Interestingly, it has been reported
that siRNAs targeting granulin-epithelin precursor (GEP) or shRNAs
targeting human matrix metalloproteinase-26 (MMP-26) speciﬁcally
depleted the targeted proteins, and the non-relevant α-tubulin (and
β-actin) protein was also down-regulated [49,50]. Together, these
observations and our data strongly suggest that siRNA-induced α-
tubulin reduction can be a common effect of siRNA transfection.
In fact a careful study of several published reports that used α-tubulin
as a loading control showed signiﬁcant reductions of this protein in
siRNA treated cells, such as Fig. 4A in [51] and Fig. 1A in [52].Since the expression of many miRNA-target genes could be
non-speciﬁcally mis-regulated by siRNA transfection, such mis-
regulation may in turn cause other unexpected effects that can
occur at the protein level, as we exempliﬁed here for α-tubulin.
siRNA induced non-speciﬁc reduction of P53 and P21 proteins
has been reported, and the reduction of the proteins was not
highly related to their mRNA levels [53], indicating that many pro-
teins could be affected in a similar mechanism. The detrimental
effects of siRNAs on α-tubulin and many miRNAs can occur at
very low concentrations (1–5 nM, Figs. 2 and 8), depending on
cell type and transfection efﬁciency. Our ﬁndings focus attention
on the central role that limiting concentration of Ago2 plays in
normal cellular functions and suggest that oligonucleotides that
binds to Ago2 may disrupt the regulation of miRNAs, leading to
broad and unpredictable effects on the phenotypes.
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